These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1003 related articles for article (PubMed ID: 22055501)

  • 1. Insulin resistance, hyperglycemia, and atherosclerosis.
    Bornfeldt KE; Tabas I
    Cell Metab; 2011 Nov; 14(5):575-85. PubMed ID: 22055501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance, metabolic stress, and atherosclerosis.
    Pansuria M; Xi H; Li L; Yang XF; Wang H
    Front Biosci (Schol Ed); 2012 Jan; 4(3):916-31. PubMed ID: 22202099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of insulin resistance and hyperglycemia in the development of atherosclerosis.
    Bansilal S; Farkouh ME; Fuster V
    Am J Cardiol; 2007 Feb; 99(4A):6B-14B. PubMed ID: 17307054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia.
    Heinonen SE; Leppänen P; Kholová I; Lumivuori H; Häkkinen SK; Bosch F; Laakso M; Ylä-Herttuala S
    Circ Res; 2007 Nov; 101(10):1058-67. PubMed ID: 17872464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated augmentation of NFAT and NOD signaling mediates proliferative VSMC phenotype switch under hyperinsulinemia.
    Shiny A; Regin B; Mohan V; Balasubramanyam M
    Atherosclerosis; 2016 Mar; 246():257-66. PubMed ID: 26814423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: diabetes and atherosclerosis--running on a common road.
    Federici M; Lauro R
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():11-5. PubMed ID: 16225464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1-mediated p53/KLF4 complex stabilization.
    Xi G; Shen X; Wai C; White MF; Clemmons DR
    J Biol Chem; 2019 Feb; 294(7):2407-2421. PubMed ID: 30578299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.
    Li J; Wang Q; Chai W; Chen MH; Liu Z; Shi W
    Cardiovasc Diabetol; 2011 Dec; 10():117. PubMed ID: 22204493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and atherosclerosis.
    Nigro J; Osman N; Dart AM; Little PJ
    Endocr Rev; 2006 May; 27(3):242-59. PubMed ID: 16492903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated Ca2+ sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells.
    Navedo MF; Takeda Y; Nieves-Cintrón M; Molkentin JD; Santana LF
    Am J Physiol Cell Physiol; 2010 Feb; 298(2):C211-20. PubMed ID: 19846755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance aggravates atherosclerosis by reducing vascular smooth muscle cell survival and increasing CX3CL1/CX3CR1 axis.
    Martínez-Hervás S; Vinué A; Núñez L; Andrés-Blasco I; Piqueras L; Real JT; Ascaso JF; Burks DJ; Sanz MJ; González-Navarro H
    Cardiovasc Res; 2014 Jul; 103(2):324-36. PubMed ID: 24788416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice.
    Terasaki M; Hiromura M; Mori Y; Kohashi K; Nagashima M; Kushima H; Watanabe T; Hirano T
    PLoS One; 2015; 10(11):e0143396. PubMed ID: 26606676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging concepts in the pathophysiology of type 2 diabetes mellitus.
    Surampudi PN; John-Kalarickal J; Fonseca VA
    Mt Sinai J Med; 2009 Jun; 76(3):216-26. PubMed ID: 19421965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postchallenge hyperglycemia but not hyperinsulinemia is associated with angiographically documented coronary atherosclerosis in Korean subjects.
    Kim HK; Lee SK; Suh CJ; Yoon HJ; Lee KY; Park HY; Kang MH
    Diabetes Res Clin Pract; 2003 Feb; 59(2):129-36. PubMed ID: 12560162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of coronary artery disease and percutaneous intervention on the cardiac metabolism of nonesterified fatty acids and insulin: Implications of diabetes mellitus.
    Jaumdally RJ; Lip GY; Patel JV; MacFadyen RJ; Varma C
    J Intern Med; 2009 Jun; 265(6):689-97. PubMed ID: 19226374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of adiposity to subclinical atherosclerosis in obese patients with type 2 diabetes.
    Hegazi RA; Sutton-Tyrrell K; Evans RW; Kuller LH; Belle S; Yamamoto M; Edmundowicz D; Kelley DE
    Obes Res; 2003 Dec; 11(12):1597-605. PubMed ID: 14694226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and atherosclerosis.
    Raghavan VA
    Heart Fail Clin; 2012 Oct; 8(4):575-87. PubMed ID: 22999241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative Stress Genes, Antioxidants and Coronary Artery Disease in Type 2 Diabetes Mellitus.
    Tibaut M; Petrovič D
    Cardiovasc Hematol Agents Med Chem; 2016; 14(1):23-38. PubMed ID: 27052028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.
    Iozzo P; Chareonthaitawee P; Dutka D; Betteridge DJ; Ferrannini E; Camici PG
    Diabetes; 2002 Oct; 51(10):3020-4. PubMed ID: 12351442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of Insulin Receptor Substrate 1 during Hyperglycemia Induces Vascular Smooth Muscle Cell Dedifferentiation.
    Xi G; Wai C; White MF; Clemmons DR
    J Biol Chem; 2017 Feb; 292(5):2009-2020. PubMed ID: 28003360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.